Development and evaluation of a PCR and mass spectroscopy (PCR–MS)-based method for quantitative, type-specific detection of human papillomavirus

Journal of Virological Methods - Tập 160 - Trang 78-84 - 2009
Divya A. Patel1, Yang-Jen Shih2, Duane W. Newton3, Claire W. Michael3, Paul A. Oeth4, Michael D. Kane5, Anthony W. Opipari1, Mack T. Ruffin, IV6, Linda M. Kalikin2, David M. Kurnit2
1Department of Obstetrics and Gynecology, University of Michigan Medical School, L4000 Women's Hospital, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5276, USA
2Department of Pediatrics, University of Michigan Medical School, L2225 Women's Hospital, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5244, USA
3Department of Pathology, University of Michigan Medical School, 2F461 University Hospital, 1500 E. Medical Center Drive, Ann Arbor, MI 48109-5054, USA
4Sequenom, Inc., 3595 John Hopkins Ct., San Diego, CA 92121, USA
5Department of Computer and Information Technologies, Purdue University, Knoy Building, 401 North Grant Street, West Lafayette, IN 47907, USA
6Department of Family Medicine, University of Michigan Medical School, 1018 Fuller Street, Ann Arbor, MI 48104-1213, USA

Tài liệu tham khảo

Bigras, 2005, The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women, Br. J. Cancer, 93, 575, 10.1038/sj.bjc.6602728 Bosch, 1995, Prevalence of human papillomavirus in cervical cancer: a worldwide perspective, J. Natl. Cancer Inst., 87, 796, 10.1093/jnci/87.11.796 Castle, 2005, Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities, J. Natl. Cancer Inst., 97, 1066, 10.1093/jnci/dji186 Chan, 2005, Detection and quantitation of human papillomavirus DNA in primary tumour and lymph nodes of patients with early stage cervical carcinoma, J. Clin. Virol., 33, 201, 10.1016/j.jcv.2004.10.018 Cheung, 2009, Analysis of human papillomavirus type 18 load and integration status from low-grade cervical lesion to invasive cervical cancer, J. Clin. Microbiol., 47, 287, 10.1128/JCM.01531-08 Cohen, 2008, Increased viral load correlates with improved survival in HPV-16-associated tonsil carcinoma patients, Acta Otolaryngol., 128, 583, 10.1080/00016480701558880 de Roda Husman, 1995, The use of general primers GP5 and GP6 elongated at their 3′ ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR, J. Gen. Virol., 76, 1057, 10.1099/0022-1317-76-4-1057 Demeter, 1988, Detection of human papillomavirus DNA in cell scrapes and formalin-fixed, paraffin-embedded tissue of the uterine cervix by filter in situ hybridisation, J. Med. Virol., 26, 397, 10.1002/jmv.1890260407 Ding, 2003, A high-throughput gene expression analysis technique using competitive PCR and matrix-assisted laser desorption ionization time-of-flight MS, Proc. Natl. Acad. Sci. U.S.A., 100, 3059, 10.1073/pnas.0630494100 Flint, 2004, Genome replication strategies: DNA viruses, 298 Ginocchio, 2008, Comparison of the third wave invader human papillomavirus (HPV) assay and the digene HPV hybrid capture 2 assay for detection of high-risk HPV DNA, J. Clin. Microbiol., 46, 1641, 10.1128/JCM.01824-07 Goldie, 2004, Projected clinical benefits and cost-effectiveness of a human papillomavirus 16/18 vaccine, J. Natl. Cancer Inst., 96, 604, 10.1093/jnci/djh104 Guerin-Reverchon, 1989, A comparison of methods for the detection of human papillomavirus DNA by in situ hybridization with biotinylated probes on human carcinoma cell lines. Application to wart sections, J. Immunol. Methods, 123, 167, 10.1016/0022-1759(89)90220-2 Ho, 1995, Persistent genital human papillomavirus infection as a risk factor for persistent cervical dysplasia, J. Natl. Cancer Inst., 87, 1365, 10.1093/jnci/87.18.1365 Jastania, 2006, Characteristics of apparently false-negative digene hybrid capture 2 high-risk HPV DNA testing, Am. J. Clin. Pathol., 125, 223, 10.1309/QEJBYT77YMTEVJ66 Josefsson, 2000, Viral load of human papilloma virus 16 as a determinant for development of cervical carcinoma in situ: a nested case–control study, Lancet, 355, 2189, 10.1016/S0140-6736(00)02401-6 Khan, 2005, The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice, J. Natl. Cancer Inst., 97, 1072, 10.1093/jnci/dji187 Kulmala, 2007, Prevalence of the most common high-risk HPV genotypes among women in three new independent states of the former Soviet Union, J. Med. Virol., 79, 771, 10.1002/jmv.20839 Li, 2003, Human papillomavirus positivity predicts favourable outcome for squamous carcinoma of the tonsil, Int. J. Cancer, 106, 553, 10.1002/ijc.11261 Lillo, 2008, Extralesional detection and load of human papillomavirus DNA: a possible marker of preclinical tumor spread in cervical cancer, J. Low Genit. Tract Dis., 12, 204, 10.1097/LGT.0b013e318161429e Lizard, 1993, Detection of human papillomavirus DNA in CaSki and HeLa cells by fluorescent in situ hybridization. Analysis by flow cytometry and confocal laser scanning microscopy, J. Immunol. Methods, 157, 31, 10.1016/0022-1759(93)90067-H Moberg, 2004, Type-specific associations of human papillomavirus load with risk of developing cervical carcinoma in situ, Int. J. Cancer, 112, 854, 10.1002/ijc.20480 Munoz, 2003, Epidemiologic classification of human papillomavirus types associated with cervical cancer, N. Engl. J. Med., 348, 518, 10.1056/NEJMoa021641 Munoz, 2004, Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results, J. Infect. Dis., 190, 2077, 10.1086/425907 Obiso, 2004, Digene Corporation, Pharmacogenomics, 5, 129, 10.1517/phgs.5.1.129.25678 Parkin, 2005, Global cancer statistics, 2002, CA Cancer J. Clin., 55, 74, 10.3322/canjclin.55.2.74 Saunier, 2008, Analysis of human papillomavirus type 16 (HPV16) DNA load and physical state for identification of HPV16-infected women with high-grade lesions or cervical carcinoma, J. Clin. Microbiol., 46, 3678, 10.1128/JCM.01212-08 Scheffner, 1990, The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53, Cell, 63, 1129, 10.1016/0092-8674(90)90409-8 Schlecht, 2003, Viral load as a predictor of the risk of cervical intraepithelial neoplasia, Int. J. Cancer, 103, 519, 10.1002/ijc.10846 Seme, 2006, Resolving repeatedly borderline results of Hybrid Capture 2 HPV DNA Test using polymerase chain reaction and genotyping, J. Virol. Methods, 134, 252, 10.1016/j.jviromet.2005.12.004 Swan, 1999, Human papillomavirus (HPV) DNA copy number is dependent on grade of cervical disease and HPV type, J. Clin. Microbiol., 37, 1030, 10.1128/JCM.37.4.1030-1034.1999 Syrjanen, 1991, The use of polymerase chain reaction in generation of biotinylated human papillomavirus DNA probes for in situ hybridization, J. Virol. Methods, 31, 147, 10.1016/0166-0934(91)90153-Q Wickenden, 1987, Prevalence of HPV DNA and viral copy numbers in cervical scrapes from women with normal and abnormal cervices, J. Pathol., 153, 127, 10.1002/path.1711530206 Worden, 2008, Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number, J. Clin. Oncol., 26, 3138, 10.1200/JCO.2007.12.7597 Yang, 2005, Sensitive detection of human papillomavirus in cervical, head/neck, and schistosomiasis-associated bladder malignancies, Proc. Natl. Acad. Sci. U.S.A., 102, 7683, 10.1073/pnas.0406904102 Ylitalo, 2000, Consistent high viral load of human papillomavirus 16 and risk of cervical carcinoma in situ: a nested case–control study, Lancet, 355, 2194, 10.1016/S0140-6736(00)02402-8